Clinical Trial Update: A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical pirenzepine versus placebo for peripheral neuropathy in type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy
• Peripheral Neuropathy

Drugs mentioned

• pirenzepine (pirenzepine)

Snippet

Sponsor: WinSanTor, Inc | Conditions: Peripheral Neuropathy, Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED